Amanote Research
Register
Sign In
Trends in Day 100 and 2-Year Survival After Auto-SCT for AL Amyloidosis: Outcomes Before and After 2006
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/bmt.2010.234
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
October 11, 2010
Authors
M A Gertz
M Q Lacy
A Dispenzieri
S K Kumar
F K Buadi
D Dingli
N Leung
W J Hogan
S R Hayman
Publisher
Springer Science and Business Media LLC
Related search
A Second Course of High-Dose Melphalan and Auto-SCT for the Treatment of Relapsed AL Amyloidosis
Bone Marrow Transplantation
Transplantation
Hematology
Correction: Before and After the "Appointed Day"
BMJ
Matched-Pair Analysis to Compare the Outcomes of a Second Salvage Auto-SCT to Systemic Chemotherapy Alone in Patients With Multiple Myeloma Who Relapsed After Front-Line Auto-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Day 100 Risk Assessment Tool Predicts 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The Cost of Dying: Charges Before Day 100 Predictive of Overall Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Grading Cardiac Response in AL Amyloidosis: Implications for Relapse and Survival
British Journal of Haematology
Hematology
Four-Year Survival (And Counting) After Stereotactic Radiosurgery to Nearly 100 Brain Metastases: A Case Report
Cureus
Meta-Analysis Comparing Outcomes Before and After Resuscitation Guideline Updates After Cardiac Arrest
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Necrotizing Fasciitis and the Midterm Outcomes After Survival
SAGE Open Medicine
Medicine
